Does year of radical prostatectomy independently predict outcome in prostate cancer?

Urology

Volumn 67, Issue 2, 2006, Pages 368-372

  Mitchell, Robert E ^a   Shah, Jay B ^a   Olsson, Carl A ^a   Benson, Mitchell C ^a   McKiernan, James M ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TREATMENT OUTCOME;

EID: 31944438470     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.08.036     Document Type: Article

References (17)

1. I.H. Derweesh, P.A. Kupelian, C. Zippe Continuing trends in pathological stage migration in radical prostatectomy specimens Urol Oncol 22 2004 300 306
2. C.L. Amling, M.L. Blute, S.E. Lerner Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice Mayo Clin Proc 73 1998 401 406
3. A. Jemal, T. Murray, E. Ward Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
4. P.C. Walsh, P.J. Donker Impotence following radical prostatectomy insight into etiology and prevention J Urol 128 1982 492 497
5. A.R. McCullough Prevention and management of erectile dysfunction following radical prostatectomy Urol Clin North Am 28 2001 613 627
6. J.C. Hu, K.F. Gold, C.L. Pashos Temporal trends in radical prostatectomy complications from 1991 to 1998 J Urol 169 2003 1443 1448
7. J.O. Ung, J.P. Richie, M.H. Chen Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era Urology 60 2002 458 463
8. J.H. Moul, H. Wu, L. Sun Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen an overview of the Department of Defense Center for Prostate Disease Research national database Surgery 132 2002 213 219
9. F.D. Gilliland, W.C. Hunt, C.R. Key Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era Urology 48 1996 67 71
10. M. Han, A.W. Partin, S. Piantadosi Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer J Urol 166 2001 416 419
11. American Joint Committee on Cancer O.H. Beahrs, D.E. Henson, R.V.P. Hutter Manual for Staging of Cancer 4th ed. 1992 JB Lippincott Philadelphia 181 186
12. I. Cagiannos, P. Karakiewicz, M. Graefen Is year of radical prostatectomy a predictor of outcome in prostate cancer? J Urol 171 2004 692 696
13. K.A. Roehl, M. Han, C.G. Ramos Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients long-term results J Urol 172 2004 910 914
14. T.A. Stamey, M. Raimondo, C.M. Yemoto Effect of ageing of morphologic and clinical predictors of prostate cancer progression Prostate J 2 2000 157 161
15. S.J. Freedland, J.C. Presti Jr, C.J. Kane Do younger men have better biochemical outcomes after radical prostatectomy? Urology 63 2004 518 522
16. T.A. Stamey, M. Caldwell, J.E. McNeal The prostate specific antigen era in the United States is over for prostate cancer what happened in the last 20 years? J Urol 172 2004 1297 1301
17. A.A. Renshaw, J.P. Richie, K.R. Loughlin Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens validation in a cohort of 434 patients Am J Clin Pathol 111 1999 641 644